{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24730500",
  "DateCompleted": {
    "Year": "2014",
    "Month": "10",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "07",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/15265161.2014.889956"
    ],
    "Journal": {
      "ISSN": "1536-0075",
      "JournalIssue": {
        "Volume": "14",
        "Issue": "4",
        "PubDate": {
          "Year": "2014"
        }
      },
      "Title": "The American journal of bioethics : AJOB",
      "ISOAbbreviation": "Am J Bioeth"
    },
    "ArticleTitle": "Ethics of continuing to provide a drug on an open-label extension study for an \"unapproved indication\".",
    "Pagination": {
      "StartPage": "56",
      "MedlinePgn": "56"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "a Johns Hopkins Berman Institute of Bioethics and Johns Hopkins Bloomberg School of Public Health."
          }
        ],
        "LastName": "Taylor",
        "ForeName": "Holly A",
        "Initials": "HA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kuwana",
        "ForeName": "Ellen",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wilfond",
        "ForeName": "Benjamin S",
        "Initials": "BS"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Bioeth",
    "NlmUniqueID": "100898738",
    "ISSNLinking": "1526-5161"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antihypertensive Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Am J Bioeth. 2014;14(4):57-8",
      "PMID": "24730501"
    },
    {
      "RefSource": "Am J Bioeth. 2014;14(4):59-60",
      "PMID": "24730502"
    },
    {
      "RefSource": "Am J Bioeth. 2014;14(4):60-1",
      "PMID": "24730503"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "economics"
      ],
      "DescriptorName": "Antihypertensive Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Australia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Canada"
    },
    {
      "QualifierName": [
        "standards"
      ],
      "DescriptorName": "Drug Prescriptions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ethics, Research"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Hypertension, Pulmonary"
    },
    {
      "QualifierName": [
        "ethics"
      ],
      "DescriptorName": "Multicenter Studies as Topic"
    },
    {
      "QualifierName": [
        "ethics"
      ],
      "DescriptorName": "Off-Label Use"
    },
    {
      "QualifierName": [
        "ethics"
      ],
      "DescriptorName": "Randomized Controlled Trials as Topic"
    },
    {
      "QualifierName": [
        "ethics"
      ],
      "DescriptorName": "Research Personnel"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United States"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Walking"
    }
  ]
}